Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1

10 Jun 2021

Abstract excerpt

The ongoing outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a great threat to the public health of people and the normal economic and social development around the world. As of January 8, 2021, more than 88 million people were infected with SARS-CoV-2, resulting in more than 1.9 million death. Early detection and treatment of SARS-CoV-2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced biosensing and bioanalysis techniques
Share to Biosensors and Analytical Detection
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34112756
DOI: 10.1038/s41392-021-00649-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1PMID 34112756Read ↗

Discovery of Aptamers Targeting the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein.Semantic proximity Read ↗

A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry.Semantic proximity Read ↗

Broadly neutralizing aptamers to SARS-CoV-2: A diverse panel of modified DNA antiviral agentsSemantic proximity Read ↗

A SARS‐CoV‐2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD‐Independent Mechanism**Semantic proximity Read ↗

TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351)Semantic proximity Read ↗

In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike ProteinSemantic proximity Read ↗

SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2Semantic proximity Read ↗

SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2Semantic proximity Read ↗

Aptamer‐based strategies against SARS‐CoV‐2 virusesSemantic proximity Read ↗

Spherical Neutralizing Aptamer Inhibits SARS-CoV-2 Infection and Suppresses Mutational Escape.Semantic proximity Read ↗

A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS‐CoV‐2 Variants of ConcernSemantic proximity Read ↗

Aptamer BC 007 - Efficient binder of spreading-crucial SARS-CoV-2 proteinsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.